Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +2.46% | +13.66% | -10.34% |
Evolution of the average Target Price on Mersana Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Mersana Therapeutics, Inc.
JPMorgan Chase | |
Truist Securities | |
Wedbush | |
Guggenheim | |
Citigroup | |
Baird | |
SVB Securities LLC | |
HC Wainwright | |
Credit Suisse |
EPS Revisions
- Stock Market
- Equities
- MRSN Stock
- Consensus Mersana Therapeutics, Inc.